The Affordable Care Act's impact on insurance coverage & treatment in patients with HIV and cancer

November 11, 2019

A recent study reveals that, for people living with both HIV and cancer (PLWHC), implementation of the Patient Protection and Affordable Care Act (ACA) improved insurance coverage, both in states that expanded Medicaid coverage and those that did not. Lack of insurance is still common in non-expansion states, however, and patients who are minorities or have low income are most likely to live in these states. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

The study is the first to measure the benefits of the ACA on insurance coverage and cancer treatment in PLWHC. The ACA created several new options for states regarding Medicaid. States that exercised the option to expand Medicaid eligibility to adults with incomes up to 138 percent of the federal poverty level, or developed new state plans under the ACA, were defined as expansion states. All states that did not fully expand Medicaid by 2015 were defined as non-expansion states. In this study, which was conducted by a team led by Gita Suneja, MD, MSHP, at the Duke University School of Medicine (currently at Huntsman Cancer Institute at the University of Utah), the pre-ACA era was defined as 2011-2013 and the post-ACA era was defined as 2014-2015.

In the analysis, of 4,794 U.S. adults with HIV who were diagnosed with cancer from 2011-2015, 49 percent resided in non-expansion states and were more often uninsured (16.7 percent versus 4.2 percent), non-white (65.2 percent versus 60.2 percent), and low income (36.3 percent versus 26.9 percent) than those in expansion states. After 2014, the percentage of PLWHC who were uninsured decreased in expansion states from 4.9 percent to 3 percent and in non-expansion states from 17.6 percent to 14.6 percent, possibly due to increased Medicaid coverage in expansion states (36.9 percent to 39.2 percent) and increased private insurance coverage in non-expansion states (29.5 percent to 34.7 percent). There was no significant difference in the likelihood that PLWHC would receive cancer treatment between expansion and non-expansion states.

"A concerning finding is that people with HIV most at risk for not receiving cancer treatment--for example those of Black/African-American race or with low income--were more likely to live in states that did not expand Medicaid. In these non-expansion states, the percentage of uninsured people living with HIV and cancer was five times higher compared with expansion states," said Dr. Suneja. "We didn't see differences in insurance coverage translate to differences in cancer treatment; however, longer follow-up time is needed to fully evaluate this and the impact of insurance on cancer survival for people with HIV. Regardless, further insurance coverage options are urgently needed to ensure access to the full spectrum of cancer services--including prevention, screening, diagnosis, management, and surveillance--and ultimately improve cancer outcomes for this population."
This study was supported by funding from the American Cancer Society intramural research program and the intramural program of the National Cancer Institute

Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:

Penny Smith +44 (0) 1243 770448 (UK)
Follow us on Twitter @WileyNews

Full Citation: "The impact of the Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected cancer patients in the U.S." Kelsey L. Corrigan, Leticia Nogueira, K. Robin Yabroff, Chun Chieh Lin, Xuesong Han, Junzo P. Chino, Anna E. Coghill, Meredith Shiels, Ahmedin Jemal, and Gita Suneja. CANCER; Published Online: November 11, 2019 (DOI: 10.1002/cncr.32563).

URL Upon Publication:

Author Contact: Ashlee Bright, of the communications and public affairs office Huntsman Cancer Institute at the University of Utah, at or +1 801-585-1954.

About the Journal

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow us on Twitter @JournalCancer

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to